KIN

Kindred Biosciences Announces First Quarter 2014 Financial Results and Completion of Enrollment in CereKin Pivotal Study

[PR Newswire] – SAN FRANCISCO, May 12, 2014 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended March 31, 2014. In addition, Kindred Bio announced that it has … moreView todays social media effects on KINView the latest stocks trending across Twitter. Click to view dashboardSee who Kindred is hiring next, click here to […]

Kindred Bio to Announce First Quarter 2014 Financial Results on Monday, May 12th

[PR Newswire] – SAN FRANCISCO, May 6, 2014 /PRNewswire/ — Kindred Biosciences, Inc. (KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it will release its first quarter 2014 financial results on Ma moreView todays social media effects on KINView the latest stocks trending across Twitter. Click to view dashboardSee who Kindred is […]

Kindred Bio to Present at Needham 13th Annual Healthcare Conference

[PR Newswire] – SAN FRANCISCO, April 4, 2014 /PRNewswire/ — Kindred Biosciences, Inc. (KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will present at Needham 13th Annual Healthcare Conference moreView todays social media effects on KINView the latest stocks trending across Twitter. Click to view dashboardSee who Kindred is hiring next, […]

Kindred Bio to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 6th

[PR Newswire] – SAN FRANCISCO, Feb. 27, 2014 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it will release … moreView todays social media effects on KINView the latest stocks trending across Twitter. Click to view dashboardSee who Kindred is hiring next, click here to view […]

Kindred Bio to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 6th

[PR Newswire] – SAN FRANCISCO, Feb. 27, 2014 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it will release … moreView todays social media effects on KINView the latest stocks trending across Twitter. Click to view dashboardSee who Kindred is hiring next, click here to view […]